Amneal Pharmaceuticals (AMRX) Shareholder's Equity (2017 - 2026)

Amneal Pharmaceuticals (AMRX) Shareholder's Equity (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 8.23 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.75 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.21 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 446.17 Mn
10 Amneal Pharmaceuticals 4.34 Bn 4.33 Bn 320.11 Mn -45.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.41 Mn
Dec 31, 2025 -70.79 Mn
Sep 30, 2025 -109.96 Mn
Jun 30, 2025 -112.53 Mn
Mar 31, 2025 -132.00 Mn
Dec 31, 2024 -109.51 Mn
Sep 30, 2024 -93.57 Mn
Jun 30, 2024 -57.49 Mn
Mar 31, 2024 -63.63 Mn
Dec 31, 2023 20.01 Mn
Sep 30, 2023 154.24 Mn
Jun 30, 2023 150.77 Mn
Mar 31, 2023 134.67 Mn
Dec 31, 2022 183.98 Mn
Sep 30, 2022 194.29 Mn
Jun 30, 2022 172.99 Mn
Mar 31, 2022 407.41 Mn
Dec 31, 2021 366.97 Mn
Sep 30, 2021 383.17 Mn
Jun 30, 2021 390.27 Mn